Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2001 Mar;94(3):119–123. doi: 10.1177/014107680109400305

BCG immunotherapy for superficial bladder cancer.

C R Lockyer 1, D A Gillatt 1
PMCID: PMC1297926  PMID: 11285791

Full Text

The Full Text of this article is available as a PDF (83.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hickey D. P., Vivas C. A., Jordan M. L., Lopatin W. B., Hrebinko R., O'Donovan R., Hakala T. R. Highly sensitized patients with delayed graft function: a management protocol. J Urol. 1991 Jan;145(1):131–134. doi: 10.1016/s0022-5347(17)38268-x. [DOI] [PubMed] [Google Scholar]
  2. Pagano F., Bassi P., Milani C., Meneghini A., Maruzzi D., Garbeglio A. A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective? J Urol. 1991 Jul;146(1):32–35. doi: 10.1016/s0022-5347(17)37707-8. [DOI] [PubMed] [Google Scholar]
  3. Perlaky L., Valdez B. C., Busch R. K., Larson R. G., Jhiang S. M., Zhang W. W., Brattain M., Busch H. Increased growth of NIH/3T3 cells by transfection with human p120 complementary DNA and inhibition by a p120 antisense construct. Cancer Res. 1992 Jan 15;52(2):428–436. [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES